| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart-Assist Devices | 77 | 2013 | 1093 | 3.290 |
Why?
|
| Heart Failure | 42 | 2014 | 2416 | 1.580 |
Why?
|
| Heart Transplantation | 43 | 2014 | 894 | 1.490 |
Why?
|
| Assisted Circulation | 14 | 2012 | 37 | 1.250 |
Why?
|
| Mast Cells | 7 | 2008 | 83 | 1.020 |
Why?
|
| Heart, Artificial | 17 | 2008 | 69 | 0.800 |
Why?
|
| Myocardium | 19 | 2011 | 1046 | 0.630 |
Why?
|
| Hemodynamics | 25 | 2013 | 868 | 0.590 |
Why?
|
| Graft Rejection | 15 | 2014 | 627 | 0.560 |
Why?
|
| Equipment Design | 29 | 2005 | 614 | 0.560 |
Why?
|
| Tissue Donors | 9 | 2014 | 525 | 0.530 |
Why?
|
| Cardiac Output, Low | 5 | 2008 | 68 | 0.520 |
Why?
|
| Coronary Artery Bypass | 12 | 2009 | 531 | 0.480 |
Why?
|
| Ventricular Remodeling | 7 | 2007 | 187 | 0.450 |
Why?
|
| Cardiac Surgical Procedures | 10 | 2011 | 1159 | 0.410 |
Why?
|
| Societies, Scientific | 1 | 2012 | 27 | 0.400 |
Why?
|
| Artificial Organs | 1 | 2012 | 13 | 0.400 |
Why?
|
| Transplant Recipients | 1 | 2014 | 225 | 0.390 |
Why?
|
| Cardiopulmonary Bypass | 15 | 1997 | 365 | 0.350 |
Why?
|
| Transplantation, Heterotopic | 5 | 2014 | 29 | 0.350 |
Why?
|
| Middle Aged | 104 | 2014 | 29378 | 0.350 |
Why?
|
| Humans | 199 | 2014 | 133858 | 0.340 |
Why?
|
| Ventricular Function, Right | 3 | 2004 | 116 | 0.340 |
Why?
|
| Organ Transplantation | 2 | 2008 | 186 | 0.320 |
Why?
|
| Periodicals as Topic | 1 | 2012 | 206 | 0.320 |
Why?
|
| Postoperative Complications | 29 | 2008 | 3229 | 0.310 |
Why?
|
| Hemolysis | 18 | 2004 | 113 | 0.310 |
Why?
|
| History, 20th Century | 5 | 2012 | 398 | 0.300 |
Why?
|
| Coronary Occlusion | 1 | 2009 | 29 | 0.300 |
Why?
|
| Ventricular Function, Left | 10 | 2005 | 541 | 0.290 |
Why?
|
| Adult | 92 | 2014 | 31926 | 0.290 |
Why?
|
| Thrombosis | 13 | 2007 | 537 | 0.280 |
Why?
|
| Cathepsins | 1 | 2007 | 26 | 0.270 |
Why?
|
| Models, Cardiovascular | 11 | 2013 | 190 | 0.270 |
Why?
|
| Hypertension, Pulmonary | 2 | 2009 | 467 | 0.270 |
Why?
|
| Male | 113 | 2014 | 65821 | 0.260 |
Why?
|
| Tumor Necrosis Factor-alpha | 7 | 2005 | 707 | 0.260 |
Why?
|
| Equipment Safety | 3 | 2005 | 37 | 0.260 |
Why?
|
| General Surgery | 1 | 2008 | 217 | 0.250 |
Why?
|
| Cardiomyopathy, Dilated | 8 | 2006 | 217 | 0.250 |
Why?
|
| Serine Endopeptidases | 1 | 2007 | 204 | 0.250 |
Why?
|
| Lung Transplantation | 15 | 1997 | 335 | 0.250 |
Why?
|
| Heart Ventricles | 12 | 2006 | 799 | 0.240 |
Why?
|
| Female | 108 | 2014 | 71588 | 0.230 |
Why?
|
| History, 21st Century | 3 | 2012 | 279 | 0.230 |
Why?
|
| Heart Septal Defects, Atrial | 2 | 2005 | 127 | 0.230 |
Why?
|
| Cardiomyopathies | 5 | 2006 | 514 | 0.220 |
Why?
|
| Patient Selection | 3 | 2003 | 734 | 0.220 |
Why?
|
| Bioprosthesis | 2 | 2004 | 117 | 0.210 |
Why?
|
| Aged | 55 | 2012 | 21722 | 0.210 |
Why?
|
| Polytetrafluoroethylene | 5 | 2008 | 76 | 0.210 |
Why?
|
| Shock, Cardiogenic | 3 | 2008 | 210 | 0.200 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2004 | 88 | 0.200 |
Why?
|
| Heart Valve Prosthesis Implantation | 3 | 2008 | 452 | 0.200 |
Why?
|
| Heart Valve Prosthesis | 6 | 2004 | 309 | 0.200 |
Why?
|
| Cardiology | 1 | 2008 | 520 | 0.200 |
Why?
|
| Aorta | 6 | 2013 | 555 | 0.200 |
Why?
|
| Biliopancreatic Diversion | 1 | 2002 | 4 | 0.200 |
Why?
|
| Blood Vessel Prosthesis | 14 | 2008 | 539 | 0.190 |
Why?
|
| Foreign Bodies | 1 | 2003 | 109 | 0.190 |
Why?
|
| Pulsatile Flow | 10 | 2014 | 128 | 0.190 |
Why?
|
| Prosthesis Design | 14 | 2010 | 711 | 0.180 |
Why?
|
| Postoperative Care | 7 | 2001 | 310 | 0.180 |
Why?
|
| Tissue Engineering | 2 | 2014 | 184 | 0.180 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2001 | 68 | 0.180 |
Why?
|
| Monitoring, Physiologic | 8 | 2000 | 388 | 0.180 |
Why?
|
| Heart | 8 | 1999 | 749 | 0.170 |
Why?
|
| Carotid Arteries | 5 | 2011 | 151 | 0.170 |
Why?
|
| Survival Rate | 7 | 2014 | 2207 | 0.170 |
Why?
|
| Aortic Valve Stenosis | 1 | 2004 | 346 | 0.160 |
Why?
|
| Obesity, Morbid | 1 | 2002 | 212 | 0.160 |
Why?
|
| Myocytes, Cardiac | 5 | 2011 | 672 | 0.160 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2001 | 283 | 0.150 |
Why?
|
| Heart-Lung Transplantation | 6 | 2006 | 24 | 0.150 |
Why?
|
| Cattle | 21 | 2001 | 588 | 0.150 |
Why?
|
| Blood Flow Velocity | 12 | 2012 | 467 | 0.150 |
Why?
|
| Biocompatible Materials | 7 | 1999 | 135 | 0.150 |
Why?
|
| Prosthesis Implantation | 6 | 2008 | 149 | 0.140 |
Why?
|
| Ventricular Function | 3 | 2010 | 94 | 0.130 |
Why?
|
| Arteriovenous Shunt, Surgical | 4 | 1986 | 94 | 0.130 |
Why?
|
| Anticoagulants | 1 | 2001 | 598 | 0.130 |
Why?
|
| Hemostasis, Surgical | 2 | 2001 | 36 | 0.130 |
Why?
|
| Collagen | 6 | 2006 | 334 | 0.130 |
Why?
|
| Aortic Aneurysm | 5 | 2012 | 234 | 0.130 |
Why?
|
| Coronary Disease | 9 | 1999 | 721 | 0.130 |
Why?
|
| Hydrodynamics | 2 | 2013 | 28 | 0.130 |
Why?
|
| Hyperparathyroidism | 2 | 1987 | 27 | 0.120 |
Why?
|
| Parathyroid Glands | 2 | 1987 | 30 | 0.120 |
Why?
|
| Treatment Outcome | 11 | 2011 | 13010 | 0.120 |
Why?
|
| Ultrasonography | 2 | 1990 | 999 | 0.120 |
Why?
|
| Muscle, Skeletal | 2 | 2012 | 1052 | 0.120 |
Why?
|
| Blood Pressure | 8 | 2005 | 1411 | 0.120 |
Why?
|
| Contrast Media | 2 | 2011 | 512 | 0.120 |
Why?
|
| Femoral Artery | 8 | 2008 | 191 | 0.120 |
Why?
|
| Leg | 4 | 2012 | 156 | 0.120 |
Why?
|
| Dystrophin | 3 | 2004 | 44 | 0.120 |
Why?
|
| Cholecystectomy | 2 | 1993 | 65 | 0.110 |
Why?
|
| Pericardium | 2 | 2014 | 85 | 0.110 |
Why?
|
| Kidney Failure, Chronic | 5 | 1986 | 911 | 0.110 |
Why?
|
| Heart Valves | 1 | 2014 | 54 | 0.110 |
Why?
|
| Animals | 42 | 2014 | 36364 | 0.110 |
Why?
|
| Stroke Volume | 6 | 2004 | 530 | 0.110 |
Why?
|
| Multiple Organ Failure | 2 | 2008 | 144 | 0.110 |
Why?
|
| Risk Factors | 9 | 2014 | 11077 | 0.100 |
Why?
|
| Oxygen | 7 | 2012 | 577 | 0.100 |
Why?
|
| Sex Distribution | 1 | 2014 | 330 | 0.100 |
Why?
|
| Time Factors | 21 | 2006 | 6583 | 0.100 |
Why?
|
| Renal Dialysis | 5 | 1987 | 875 | 0.100 |
Why?
|
| Age Distribution | 1 | 2014 | 444 | 0.100 |
Why?
|
| United States | 9 | 2014 | 11681 | 0.100 |
Why?
|
| Transplantation, Homologous | 9 | 2008 | 693 | 0.100 |
Why?
|
| Dogs | 12 | 1992 | 800 | 0.100 |
Why?
|
| Heart Diseases | 3 | 2007 | 522 | 0.100 |
Why?
|
| Cell Phone | 1 | 2012 | 36 | 0.100 |
Why?
|
| Aneurysm | 4 | 1984 | 90 | 0.100 |
Why?
|
| Organ Preservation | 2 | 1991 | 50 | 0.100 |
Why?
|
| Vasa Vasorum | 1 | 2011 | 3 | 0.090 |
Why?
|
| Hyperemia | 1 | 2012 | 35 | 0.090 |
Why?
|
| Cardiomegaly | 2 | 2004 | 136 | 0.090 |
Why?
|
| Myocardial Ischemia | 4 | 2004 | 364 | 0.090 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 971 | 0.090 |
Why?
|
| Carotid Artery Diseases | 2 | 2011 | 148 | 0.090 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2012 | 168 | 0.090 |
Why?
|
| Muscular Diseases | 1 | 2012 | 117 | 0.090 |
Why?
|
| Carotid Intima-Media Thickness | 1 | 2011 | 79 | 0.090 |
Why?
|
| Heart-Lung Machine | 6 | 2004 | 8 | 0.090 |
Why?
|
| Microvessels | 1 | 2011 | 64 | 0.090 |
Why?
|
| Cooperative Behavior | 1 | 2012 | 233 | 0.090 |
Why?
|
| Intra-Aortic Balloon Pumping | 3 | 2003 | 47 | 0.090 |
Why?
|
| Adolescent | 27 | 2014 | 20517 | 0.090 |
Why?
|
| Comorbidity | 2 | 2014 | 1613 | 0.090 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2012 | 234 | 0.090 |
Why?
|
| Embolism | 5 | 2001 | 48 | 0.080 |
Why?
|
| Plateletpheresis | 1 | 1990 | 2 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2012 | 3846 | 0.080 |
Why?
|
| Catheterization | 5 | 2001 | 236 | 0.080 |
Why?
|
| Neovascularization, Pathologic | 1 | 2011 | 263 | 0.080 |
Why?
|
| Preoperative Care | 3 | 1999 | 372 | 0.080 |
Why?
|
| Prosthesis Failure | 2 | 2006 | 168 | 0.080 |
Why?
|
| Plasmapheresis | 1 | 1990 | 35 | 0.080 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2011 | 154 | 0.080 |
Why?
|
| Radionuclide Angiography | 1 | 1989 | 3 | 0.080 |
Why?
|
| Blood Component Removal | 1 | 1990 | 35 | 0.080 |
Why?
|
| Follow-Up Studies | 15 | 2005 | 5505 | 0.080 |
Why?
|
| Lung | 12 | 2005 | 1556 | 0.080 |
Why?
|
| Stem Cell Transplantation | 1 | 2011 | 250 | 0.080 |
Why?
|
| Urine | 1 | 1989 | 83 | 0.080 |
Why?
|
| Transplantation Immunology | 2 | 2008 | 56 | 0.080 |
Why?
|
| Materials Testing | 1 | 1989 | 80 | 0.080 |
Why?
|
| Medical Illustration | 1 | 2008 | 19 | 0.080 |
Why?
|
| Immunosuppressive Agents | 4 | 2008 | 691 | 0.080 |
Why?
|
| Tissue and Organ Procurement | 2 | 1991 | 247 | 0.080 |
Why?
|
| International Cooperation | 1 | 2009 | 167 | 0.080 |
Why?
|
| Stem Cell Factor | 1 | 2008 | 13 | 0.070 |
Why?
|
| Awards and Prizes | 1 | 2009 | 72 | 0.070 |
Why?
|
| Carpal Tunnel Syndrome | 2 | 1986 | 23 | 0.070 |
Why?
|
| Ischemia | 1 | 2012 | 383 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2008 | 65 | 0.070 |
Why?
|
| Reoperation | 4 | 2004 | 869 | 0.070 |
Why?
|
| Thromboembolism | 5 | 2008 | 91 | 0.070 |
Why?
|
| Acute Disease | 3 | 2008 | 1189 | 0.070 |
Why?
|
| Parathyroid Hormone | 2 | 1987 | 78 | 0.070 |
Why?
|
| Cathepsin G | 1 | 2007 | 4 | 0.070 |
Why?
|
| Chymases | 1 | 2007 | 8 | 0.070 |
Why?
|
| Multiple Endocrine Neoplasia | 1 | 1987 | 23 | 0.070 |
Why?
|
| Tryptases | 1 | 2007 | 20 | 0.070 |
Why?
|
| Pleural Effusion | 1 | 2008 | 109 | 0.070 |
Why?
|
| Endomyocardial Fibrosis | 1 | 2006 | 3 | 0.070 |
Why?
|
| Coronary Vessels | 2 | 1991 | 566 | 0.070 |
Why?
|
| In Vitro Techniques | 12 | 1997 | 991 | 0.070 |
Why?
|
| Retrospective Studies | 12 | 2009 | 17460 | 0.070 |
Why?
|
| Cardiac Output | 11 | 2005 | 171 | 0.070 |
Why?
|
| Intraoperative Care | 2 | 2001 | 120 | 0.070 |
Why?
|
| Receptors, Interleukin-2 | 3 | 1991 | 44 | 0.070 |
Why?
|
| Equipment Failure | 2 | 2005 | 134 | 0.070 |
Why?
|
| Necrosis | 1 | 2007 | 220 | 0.070 |
Why?
|
| Proteoglycans | 1 | 2006 | 94 | 0.060 |
Why?
|
| Extracorporeal Membrane Oxygenation | 4 | 1999 | 640 | 0.060 |
Why?
|
| Complement Membrane Attack Complex | 1 | 2006 | 7 | 0.060 |
Why?
|
| Median Nerve | 1 | 1986 | 17 | 0.060 |
Why?
|
| Nerve Compression Syndromes | 1 | 1986 | 22 | 0.060 |
Why?
|
| Incidence | 1 | 2014 | 3393 | 0.060 |
Why?
|
| Splenic Rupture | 1 | 2006 | 5 | 0.060 |
Why?
|
| Early Ambulation | 1 | 2006 | 9 | 0.060 |
Why?
|
| Angiotensin II | 1 | 2007 | 168 | 0.060 |
Why?
|
| Endothelium | 1 | 1986 | 71 | 0.060 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2006 | 161 | 0.060 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2006 | 66 | 0.060 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2006 | 59 | 0.060 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2005 | 257 | 0.060 |
Why?
|
| Albumins | 1 | 2006 | 98 | 0.060 |
Why?
|
| Rheology | 5 | 1994 | 38 | 0.060 |
Why?
|
| Aortic Aneurysm, Abdominal | 2 | 2006 | 444 | 0.060 |
Why?
|
| Hemoglobins | 8 | 1997 | 321 | 0.060 |
Why?
|
| Fluorocarbons | 1 | 2006 | 59 | 0.060 |
Why?
|
| Dextrocardia | 1 | 2005 | 9 | 0.060 |
Why?
|
| Case-Control Studies | 3 | 2008 | 3638 | 0.060 |
Why?
|
| Thrombolytic Therapy | 1 | 2007 | 209 | 0.060 |
Why?
|
| Popliteal Vein | 1 | 1984 | 9 | 0.060 |
Why?
|
| Gastroparesis | 1 | 2006 | 66 | 0.060 |
Why?
|
| Societies, Medical | 1 | 2009 | 777 | 0.060 |
Why?
|
| Algorithms | 1 | 2012 | 1732 | 0.060 |
Why?
|
| Endothelin-1 | 1 | 2005 | 45 | 0.060 |
Why?
|
| Mitral Valve | 5 | 2003 | 268 | 0.060 |
Why?
|
| Centrifugation | 5 | 1997 | 25 | 0.060 |
Why?
|
| Antibody Formation | 1 | 2005 | 278 | 0.060 |
Why?
|
| Epoprostenol | 1 | 2005 | 71 | 0.060 |
Why?
|
| Simvastatin | 1 | 2005 | 77 | 0.060 |
Why?
|
| Pulmonary Artery | 3 | 2001 | 449 | 0.060 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2004 | 55 | 0.060 |
Why?
|
| Triglycerides | 3 | 2004 | 613 | 0.060 |
Why?
|
| Intraoperative Complications | 3 | 1996 | 175 | 0.050 |
Why?
|
| Chronic Disease | 2 | 2008 | 1253 | 0.050 |
Why?
|
| Fibrosis | 5 | 2005 | 461 | 0.050 |
Why?
|
| Quality of Life | 3 | 2005 | 2132 | 0.050 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2005 | 122 | 0.050 |
Why?
|
| Brain Death | 1 | 2005 | 75 | 0.050 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 2 | 2001 | 118 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2006 | 486 | 0.050 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2008 | 563 | 0.050 |
Why?
|
| Disease Progression | 2 | 2007 | 2239 | 0.050 |
Why?
|
| Aortography | 6 | 2013 | 192 | 0.050 |
Why?
|
| Cardiomyoplasty | 1 | 2003 | 6 | 0.050 |
Why?
|
| Blood Coagulation | 3 | 2001 | 129 | 0.050 |
Why?
|
| Fibroblasts | 2 | 2006 | 922 | 0.050 |
Why?
|
| Cell Communication | 1 | 2004 | 186 | 0.050 |
Why?
|
| Biopsy | 7 | 2006 | 1304 | 0.050 |
Why?
|
| Coronary Stenosis | 1 | 2004 | 82 | 0.050 |
Why?
|
| Bronchiolitis Obliterans | 2 | 1995 | 41 | 0.050 |
Why?
|
| Extracorporeal Circulation | 8 | 1976 | 55 | 0.050 |
Why?
|
| Myocardial Revascularization | 1 | 2003 | 107 | 0.050 |
Why?
|
| Perioperative Care | 1 | 2005 | 221 | 0.050 |
Why?
|
| Respiration, Artificial | 1 | 2006 | 497 | 0.050 |
Why?
|
| Heart Neoplasms | 1 | 2003 | 106 | 0.050 |
Why?
|
| Blood Coagulation Disorders | 1 | 2003 | 106 | 0.050 |
Why?
|
| Intraoperative Period | 3 | 1991 | 74 | 0.050 |
Why?
|
| Exercise Test | 2 | 2000 | 267 | 0.050 |
Why?
|
| Angiography | 6 | 1987 | 215 | 0.050 |
Why?
|
| Antihypertensive Agents | 1 | 2005 | 409 | 0.050 |
Why?
|
| Feasibility Studies | 1 | 2005 | 817 | 0.050 |
Why?
|
| Brain Damage, Chronic | 1 | 2001 | 31 | 0.050 |
Why?
|
| S100 Proteins | 1 | 2001 | 47 | 0.050 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2001 | 31 | 0.050 |
Why?
|
| Nerve Growth Factors | 1 | 2001 | 76 | 0.050 |
Why?
|
| Premedication | 1 | 2001 | 42 | 0.050 |
Why?
|
| Waiting Lists | 2 | 2000 | 244 | 0.050 |
Why?
|
| Coronary Angiography | 3 | 1999 | 482 | 0.050 |
Why?
|
| Postoperative Period | 3 | 2000 | 353 | 0.050 |
Why?
|
| Cause of Death | 2 | 1996 | 502 | 0.050 |
Why?
|
| Evaluation Studies as Topic | 7 | 1996 | 261 | 0.040 |
Why?
|
| Microcomputers | 1 | 2001 | 12 | 0.040 |
Why?
|
| Complement Activation | 1 | 2001 | 53 | 0.040 |
Why?
|
| Oximetry | 2 | 1992 | 173 | 0.040 |
Why?
|
| Infant | 5 | 2014 | 13135 | 0.040 |
Why?
|
| Aged, 80 and over | 4 | 2006 | 7204 | 0.040 |
Why?
|
| Child, Preschool | 8 | 2014 | 14776 | 0.040 |
Why?
|
| Cell Count | 3 | 2005 | 254 | 0.040 |
Why?
|
| Blood Coagulation Factors | 1 | 2000 | 35 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 2001 | 336 | 0.040 |
Why?
|
| Hernia, Diaphragmatic, Traumatic | 3 | 1988 | 10 | 0.040 |
Why?
|
| Clinical Protocols | 1 | 2001 | 244 | 0.040 |
Why?
|
| Predictive Value of Tests | 5 | 2011 | 2292 | 0.040 |
Why?
|
| Child | 13 | 2014 | 25712 | 0.040 |
Why?
|
| Arteriosclerosis | 3 | 1989 | 149 | 0.040 |
Why?
|
| Young Adult | 1 | 2014 | 9883 | 0.040 |
Why?
|
| Graft Survival | 2 | 1994 | 558 | 0.040 |
Why?
|
| Histocytochemistry | 1 | 1999 | 99 | 0.040 |
Why?
|
| Posture | 1 | 2000 | 157 | 0.040 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2001 | 158 | 0.040 |
Why?
|
| Intermittent Claudication | 3 | 1989 | 60 | 0.040 |
Why?
|
| Models, Structural | 3 | 1993 | 50 | 0.040 |
Why?
|
| Death, Sudden, Cardiac | 2 | 1991 | 266 | 0.040 |
Why?
|
| Palliative Care | 2 | 2000 | 461 | 0.040 |
Why?
|
| Radiography | 5 | 2008 | 825 | 0.040 |
Why?
|
| Subclavian Artery | 5 | 1979 | 73 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2006 | 3064 | 0.040 |
Why?
|
| Cells, Cultured | 3 | 2014 | 3166 | 0.040 |
Why?
|
| Cell Size | 3 | 2004 | 89 | 0.040 |
Why?
|
| Opportunistic Infections | 2 | 1989 | 79 | 0.040 |
Why?
|
| Cytokines | 1 | 2005 | 1396 | 0.040 |
Why?
|
| Swine | 3 | 2014 | 1216 | 0.040 |
Why?
|
| Mediastinum | 2 | 1991 | 46 | 0.040 |
Why?
|
| Prognosis | 8 | 2011 | 5071 | 0.040 |
Why?
|
| Femoral Vein | 2 | 1991 | 49 | 0.040 |
Why?
|
| Myocardial Contraction | 1 | 1999 | 271 | 0.040 |
Why?
|
| Pulmonary Edema | 2 | 1997 | 51 | 0.040 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2005 | 756 | 0.040 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2006 | 787 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2006 | 2197 | 0.030 |
Why?
|
| Kidney | 1 | 2005 | 1410 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2000 | 431 | 0.030 |
Why?
|
| Immunohistochemistry | 4 | 2008 | 1761 | 0.030 |
Why?
|
| Arteriovenous Anastomosis | 2 | 1987 | 5 | 0.030 |
Why?
|
| Aprotinin | 1 | 1996 | 11 | 0.030 |
Why?
|
| Veins | 2 | 1984 | 108 | 0.030 |
Why?
|
| Transplantation, Autologous | 3 | 1986 | 286 | 0.030 |
Why?
|
| Hemostatics | 1 | 1996 | 63 | 0.030 |
Why?
|
| Cohort Studies | 3 | 2008 | 5173 | 0.030 |
Why?
|
| Lung Diseases | 4 | 1995 | 400 | 0.030 |
Why?
|
| Cardiac Catheterization | 4 | 2005 | 662 | 0.030 |
Why?
|
| Platelet Aggregation | 3 | 1986 | 125 | 0.030 |
Why?
|
| Inflammation | 1 | 2003 | 1595 | 0.030 |
Why?
|
| Aorta, Thoracic | 3 | 1979 | 536 | 0.030 |
Why?
|
| Blood Pressure Monitors | 1 | 1995 | 3 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 1986 | 153 | 0.030 |
Why?
|
| Prostheses and Implants | 2 | 1995 | 161 | 0.030 |
Why?
|
| Cell Differentiation | 2 | 2014 | 2026 | 0.030 |
Why?
|
| Electrocardiography, Ambulatory | 2 | 1991 | 63 | 0.030 |
Why?
|
| Magnetic Fields | 1 | 2014 | 7 | 0.030 |
Why?
|
| Blood Pressure Determination | 1 | 1995 | 115 | 0.030 |
Why?
|
| Bioreactors | 1 | 2014 | 44 | 0.030 |
Why?
|
| Radionuclide Imaging | 4 | 1991 | 151 | 0.030 |
Why?
|
| Cystic Fibrosis | 1 | 1997 | 264 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2004 | 3691 | 0.030 |
Why?
|
| Renal Artery | 2 | 1977 | 70 | 0.030 |
Why?
|
| Infusions, Intravenous | 2 | 2006 | 571 | 0.030 |
Why?
|
| Models, Theoretical | 2 | 1994 | 398 | 0.030 |
Why?
|
| Hyperplasia | 2 | 1985 | 203 | 0.030 |
Why?
|
| Polyurethanes | 5 | 1995 | 19 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2014 | 342 | 0.030 |
Why?
|
| Fetal Blood | 1 | 2014 | 179 | 0.030 |
Why?
|
| Subclavian Vein | 2 | 1972 | 22 | 0.030 |
Why?
|
| Forecasting | 3 | 2004 | 376 | 0.030 |
Why?
|
| Cyclosporine | 1 | 1993 | 148 | 0.030 |
Why?
|
| Fatal Outcome | 2 | 2005 | 377 | 0.030 |
Why?
|
| Computer Simulation | 2 | 2012 | 704 | 0.030 |
Why?
|
| Sensitivity and Specificity | 3 | 2012 | 2158 | 0.020 |
Why?
|
| Popliteal Artery | 2 | 1989 | 51 | 0.020 |
Why?
|
| Heart Arrest, Induced | 2 | 1991 | 76 | 0.020 |
Why?
|
| Systems Integration | 1 | 2012 | 28 | 0.020 |
Why?
|
| Oxygenators | 2 | 1991 | 3 | 0.020 |
Why?
|
| Histocompatibility Testing | 1 | 1993 | 151 | 0.020 |
Why?
|
| Prospective Studies | 5 | 2006 | 6654 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2012 | 3051 | 0.020 |
Why?
|
| United States National Aeronautics and Space Administration | 3 | 1997 | 20 | 0.020 |
Why?
|
| Echocardiography | 3 | 2005 | 1111 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2014 | 836 | 0.020 |
Why?
|
| Echo-Planar Imaging | 1 | 2012 | 23 | 0.020 |
Why?
|
| Diagnosis, Differential | 4 | 1986 | 1976 | 0.020 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 1992 | 133 | 0.020 |
Why?
|
| Heart Function Tests | 2 | 1991 | 58 | 0.020 |
Why?
|
| Lung Diseases, Interstitial | 1 | 1993 | 160 | 0.020 |
Why?
|
| Blotting, Western | 2 | 2006 | 1135 | 0.020 |
Why?
|
| Survival Analysis | 3 | 2005 | 1596 | 0.020 |
Why?
|
| Gene Expression | 2 | 2008 | 1614 | 0.020 |
Why?
|
| Aorta, Abdominal | 5 | 1980 | 125 | 0.020 |
Why?
|
| Anesthesia | 2 | 1993 | 214 | 0.020 |
Why?
|
| Subclavian Steal Syndrome | 1 | 1991 | 8 | 0.020 |
Why?
|
| Sex Factors | 2 | 1986 | 1384 | 0.020 |
Why?
|
| Bradycardia | 1 | 1991 | 63 | 0.020 |
Why?
|
| Cholelithiasis | 1 | 1991 | 18 | 0.020 |
Why?
|
| Creatinine | 4 | 1996 | 423 | 0.020 |
Why?
|
| Gated Blood-Pool Imaging | 1 | 1991 | 3 | 0.020 |
Why?
|
| Arrhythmias, Cardiac | 3 | 1991 | 478 | 0.020 |
Why?
|
| L-Lactate Dehydrogenase | 2 | 1996 | 67 | 0.020 |
Why?
|
| Angina Pectoris | 1 | 1991 | 65 | 0.020 |
Why?
|
| Blood Urea Nitrogen | 3 | 1996 | 77 | 0.020 |
Why?
|
| Image Enhancement | 1 | 2012 | 170 | 0.020 |
Why?
|
| Polyethylene Terephthalates | 5 | 2005 | 46 | 0.020 |
Why?
|
| Total Lung Capacity | 1 | 1990 | 13 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 1995 | 1488 | 0.020 |
Why?
|
| Regional Blood Flow | 2 | 1990 | 226 | 0.020 |
Why?
|
| Recurrence | 3 | 2007 | 1467 | 0.020 |
Why?
|
| Lymphocyte Subsets | 1 | 1990 | 41 | 0.020 |
Why?
|
| Interleukin-6 | 2 | 2005 | 453 | 0.020 |
Why?
|
| Pulmonary Ventilation | 1 | 1990 | 29 | 0.020 |
Why?
|
| Cerebrovascular Disorders | 1 | 1991 | 125 | 0.020 |
Why?
|
| Tissue Scaffolds | 1 | 2011 | 85 | 0.020 |
Why?
|
| Cytomegalovirus | 1 | 1992 | 271 | 0.020 |
Why?
|
| Calcium | 2 | 1987 | 1146 | 0.020 |
Why?
|
| Hydrocortisone | 1 | 1991 | 242 | 0.020 |
Why?
|
| Hypertension, Renal | 2 | 1985 | 41 | 0.020 |
Why?
|
| DNA, Viral | 1 | 1992 | 499 | 0.020 |
Why?
|
| Platelet Function Tests | 1 | 1990 | 41 | 0.020 |
Why?
|
| Hypertension | 2 | 2001 | 1391 | 0.020 |
Why?
|
| Oxygenators, Membrane | 5 | 1976 | 8 | 0.020 |
Why?
|
| Hemorrhage | 2 | 2005 | 507 | 0.020 |
Why?
|
| Technetium Tc 99m Aggregated Albumin | 1 | 1989 | 2 | 0.020 |
Why?
|
| Urodynamics | 1 | 1989 | 40 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2006 | 2902 | 0.020 |
Why?
|
| Endarterectomy | 1 | 1989 | 29 | 0.020 |
Why?
|
| Bacteriuria | 1 | 1989 | 48 | 0.020 |
Why?
|
| Surgical Instruments | 1 | 1989 | 58 | 0.020 |
Why?
|
| Graft Occlusion, Vascular | 2 | 1986 | 93 | 0.020 |
Why?
|
| Diagnostic Tests, Routine | 1 | 1990 | 132 | 0.020 |
Why?
|
| Regeneration | 1 | 2011 | 232 | 0.020 |
Why?
|
| Technology Assessment, Biomedical | 1 | 1988 | 35 | 0.020 |
Why?
|
| Myocardial Infarction | 4 | 1996 | 1097 | 0.020 |
Why?
|
| Exudates and Transudates | 1 | 2008 | 22 | 0.020 |
Why?
|
| Systole | 3 | 2001 | 206 | 0.020 |
Why?
|
| Esophageal Perforation | 1 | 1968 | 15 | 0.020 |
Why?
|
| Paracentesis | 1 | 2008 | 21 | 0.020 |
Why?
|
| Biomarkers | 3 | 2006 | 3422 | 0.020 |
Why?
|
| Prevalence | 2 | 2008 | 2655 | 0.020 |
Why?
|
| Wounds, Penetrating | 1 | 1988 | 141 | 0.020 |
Why?
|
| Pulmonary Wedge Pressure | 2 | 2005 | 52 | 0.020 |
Why?
|
| Diaphragm | 1 | 1988 | 100 | 0.020 |
Why?
|
| Hypoparathyroidism | 1 | 1987 | 11 | 0.020 |
Why?
|
| Naphthalenes | 1 | 1987 | 37 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2008 | 484 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 2006 | 1631 | 0.020 |
Why?
|
| Decorin | 1 | 2006 | 8 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2001 | 1047 | 0.020 |
Why?
|
| Platelet Adhesiveness | 3 | 1975 | 41 | 0.020 |
Why?
|
| Texas | 3 | 1991 | 3684 | 0.020 |
Why?
|
| Ulnar Nerve | 1 | 1986 | 11 | 0.020 |
Why?
|
| Hematocrit | 3 | 1995 | 116 | 0.020 |
Why?
|
| Hemothorax | 2 | 2005 | 20 | 0.020 |
Why?
|
| Thoracic Injuries | 4 | 1979 | 93 | 0.020 |
Why?
|
| Tissue Adhesions | 1 | 1986 | 31 | 0.020 |
Why?
|
| Remission Induction | 1 | 2007 | 308 | 0.020 |
Why?
|
| Sarcoidosis, Pulmonary | 1 | 2006 | 10 | 0.020 |
Why?
|
| Heart Valve Diseases | 2 | 1986 | 181 | 0.020 |
Why?
|
| Emergencies | 2 | 1986 | 185 | 0.020 |
Why?
|
| Vascular Resistance | 2 | 1985 | 194 | 0.020 |
Why?
|
| Gastric Emptying | 1 | 2006 | 78 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 1987 | 200 | 0.020 |
Why?
|
| Physical Therapy Modalities | 1 | 2006 | 61 | 0.020 |
Why?
|
| Pilot Projects | 1 | 1990 | 1485 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2006 | 338 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 1326 | 0.010 |
Why?
|
| Pneumonia | 1 | 1989 | 342 | 0.010 |
Why?
|
| Blood Viscosity | 1 | 1985 | 13 | 0.010 |
Why?
|
| Renal Artery Obstruction | 2 | 1977 | 42 | 0.010 |
Why?
|
| Methods | 6 | 1982 | 144 | 0.010 |
Why?
|
| Endocarditis, Bacterial | 1 | 1986 | 137 | 0.010 |
Why?
|
| Biomedical Engineering | 2 | 1992 | 26 | 0.010 |
Why?
|
| Sarcomeres | 1 | 2004 | 34 | 0.010 |
Why?
|
| Equipment Failure Analysis | 1 | 2005 | 88 | 0.010 |
Why?
|
| Rats, Zucker | 1 | 2004 | 41 | 0.010 |
Why?
|
| Elasticity | 1 | 1985 | 94 | 0.010 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2005 | 44 | 0.010 |
Why?
|
| Myosins | 1 | 2004 | 47 | 0.010 |
Why?
|
| Anticholesteremic Agents | 1 | 1987 | 245 | 0.010 |
Why?
|
| Hypertrophy | 1 | 2005 | 104 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2005 | 149 | 0.010 |
Why?
|
| HSP47 Heat-Shock Proteins | 1 | 2004 | 4 | 0.010 |
Why?
|
| Carbon Dioxide | 5 | 1997 | 289 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2005 | 146 | 0.010 |
Why?
|
| Extracellular Space | 1 | 2004 | 89 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2005 | 444 | 0.010 |
Why?
|
| Perfusion | 1 | 1985 | 214 | 0.010 |
Why?
|
| Forearm | 1 | 1983 | 48 | 0.010 |
Why?
|
| Diabetic Nephropathies | 1 | 1985 | 114 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2011 | 2539 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 1983 | 104 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 2004 | 246 | 0.010 |
Why?
|
| Catheters, Indwelling | 1 | 1984 | 142 | 0.010 |
Why?
|
| Cell Separation | 1 | 2004 | 234 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2006 | 474 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 1985 | 207 | 0.010 |
Why?
|
| Heat-Shock Proteins | 1 | 2004 | 203 | 0.010 |
Why?
|
| Sepsis | 1 | 2008 | 516 | 0.010 |
Why?
|
| Turkey | 1 | 2003 | 64 | 0.010 |
Why?
|
| Particle Size | 4 | 1975 | 145 | 0.010 |
Why?
|
| Pneumonia, Viral | 3 | 1992 | 399 | 0.010 |
Why?
|
| Anthropometry | 2 | 1994 | 202 | 0.010 |
Why?
|
| S100 Calcium Binding Protein beta Subunit | 1 | 2001 | 17 | 0.010 |
Why?
|
| Hematologic Tests | 1 | 1982 | 37 | 0.010 |
Why?
|
| Leukocyte Elastase | 1 | 2001 | 22 | 0.010 |
Why?
|
| Complement C3a | 1 | 2001 | 19 | 0.010 |
Why?
|
| Complement C5a | 1 | 2001 | 25 | 0.010 |
Why?
|
| Staphylococcal Infections | 1 | 1986 | 573 | 0.010 |
Why?
|
| Critical Illness | 1 | 2006 | 622 | 0.010 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 1992 | 157 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2005 | 1315 | 0.010 |
Why?
|
| beta-Thromboglobulin | 1 | 2000 | 4 | 0.010 |
Why?
|
| alpha-2-Antiplasmin | 1 | 2000 | 5 | 0.010 |
Why?
|
| Platelet Factor 4 | 1 | 2000 | 23 | 0.010 |
Why?
|
| Nervous System Diseases | 1 | 1985 | 408 | 0.010 |
Why?
|
| Actuarial Analysis | 1 | 2000 | 33 | 0.010 |
Why?
|
| Antithrombin III | 1 | 2000 | 26 | 0.010 |
Why?
|
| Respiratory Insufficiency | 2 | 1973 | 239 | 0.010 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2003 | 381 | 0.010 |
Why?
|
| Electric Power Supplies | 2 | 1991 | 19 | 0.010 |
Why?
|
| Solubility | 2 | 1991 | 144 | 0.010 |
Why?
|
| Organ Size | 1 | 2001 | 466 | 0.010 |
Why?
|
| Heparin | 3 | 1996 | 226 | 0.010 |
Why?
|
| Filtration | 3 | 1975 | 24 | 0.010 |
Why?
|
| Antithrombins | 1 | 2000 | 57 | 0.010 |
Why?
|
| Health Care Rationing | 1 | 2000 | 61 | 0.010 |
Why?
|
| Thallium Radioisotopes | 1 | 1999 | 8 | 0.010 |
Why?
|
| Middle Cerebral Artery | 1 | 2000 | 117 | 0.010 |
Why?
|
| Wounds, Gunshot | 4 | 1970 | 148 | 0.010 |
Why?
|
| Dobutamine | 1 | 1999 | 59 | 0.010 |
Why?
|
| Peptide Hydrolases | 1 | 2000 | 151 | 0.010 |
Why?
|
| Blood Cell Count | 2 | 1996 | 70 | 0.010 |
Why?
|
| Vimentin | 1 | 1999 | 70 | 0.010 |
Why?
|
| Fibronectins | 1 | 1999 | 112 | 0.010 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 1999 | 105 | 0.010 |
Why?
|
| Adrenergic beta-Agonists | 1 | 1999 | 94 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 1991 | 866 | 0.010 |
Why?
|
| Apoptosis | 1 | 2006 | 1931 | 0.010 |
Why?
|
| Age Factors | 2 | 2000 | 2975 | 0.010 |
Why?
|
| Carotid Artery, Internal | 1 | 1979 | 65 | 0.010 |
Why?
|
| Registries | 1 | 2005 | 1561 | 0.010 |
Why?
|
| Oscillometry | 2 | 1995 | 15 | 0.010 |
Why?
|
| Kidney Transplantation | 2 | 1975 | 686 | 0.010 |
Why?
|
| Rats | 1 | 2004 | 3880 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2006 | 2656 | 0.010 |
Why?
|
| Anuria | 1 | 1977 | 13 | 0.010 |
Why?
|
| Cholesterol | 2 | 1993 | 574 | 0.010 |
Why?
|
| Oliguria | 1 | 1977 | 20 | 0.010 |
Why?
|
| Aortic Rupture | 1 | 1978 | 120 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2005 | 1911 | 0.010 |
Why?
|
| Diffusion | 1 | 1997 | 58 | 0.010 |
Why?
|
| Cerebrovascular Circulation | 1 | 2000 | 474 | 0.010 |
Why?
|
| Liver Diseases | 1 | 2001 | 388 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2003 | 1314 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 2001 | 504 | 0.010 |
Why?
|
| Blood Transfusion | 2 | 1996 | 321 | 0.010 |
Why?
|
| Disposable Equipment | 1 | 1976 | 18 | 0.010 |
Why?
|
| Quality Control | 1 | 1996 | 127 | 0.010 |
Why?
|
| Platelet Count | 1 | 1996 | 143 | 0.010 |
Why?
|
| Infusion Pumps, Implantable | 1 | 1996 | 42 | 0.010 |
Why?
|
| Tissue Preservation | 1 | 1975 | 16 | 0.010 |
Why?
|
| Aspartate Aminotransferases | 1 | 1996 | 86 | 0.010 |
Why?
|
| Culture Media | 1 | 1996 | 184 | 0.010 |
Why?
|
| Blood Loss, Surgical | 1 | 1996 | 159 | 0.010 |
Why?
|
| Polycarboxylate Cement | 1 | 1995 | 2 | 0.010 |
Why?
|
| Patient Care Team | 1 | 2000 | 573 | 0.010 |
Why?
|
| Carbon | 2 | 1973 | 99 | 0.010 |
Why?
|
| Cadaver | 1 | 1975 | 141 | 0.010 |
Why?
|
| Alanine Transaminase | 1 | 1996 | 162 | 0.010 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2000 | 471 | 0.010 |
Why?
|
| Electricity | 1 | 1995 | 10 | 0.010 |
Why?
|
| Oxygen Inhalation Therapy | 2 | 1992 | 92 | 0.010 |
Why?
|
| Bilirubin | 1 | 1996 | 131 | 0.010 |
Why?
|
| Disease Models, Animal | 2 | 2004 | 4771 | 0.010 |
Why?
|
| Spirometry | 1 | 1995 | 74 | 0.010 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 1995 | 141 | 0.010 |
Why?
|
| Decision Making | 1 | 2000 | 696 | 0.010 |
Why?
|
| Pseudomonas aeruginosa | 1 | 1996 | 177 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 1997 | 567 | 0.010 |
Why?
|
| Endocardium | 1 | 1994 | 56 | 0.010 |
Why?
|
| Models, Biological | 3 | 1987 | 1533 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2004 | 1406 | 0.010 |
Why?
|
| Observer Variation | 1 | 1995 | 312 | 0.010 |
Why?
|
| Cobalt | 1 | 1993 | 18 | 0.010 |
Why?
|
| Tungsten | 1 | 1993 | 6 | 0.010 |
Why?
|
| Blood Transfusion, Autologous | 1 | 1974 | 35 | 0.010 |
Why?
|
| Blood Preservation | 1 | 1974 | 32 | 0.010 |
Why?
|
| Giant Cells | 1 | 1993 | 36 | 0.010 |
Why?
|
| Aortic Valve Insufficiency | 1 | 1975 | 152 | 0.010 |
Why?
|
| Blood Chemical Analysis | 1 | 1994 | 85 | 0.010 |
Why?
|
| Metals | 1 | 1993 | 64 | 0.010 |
Why?
|
| Occupational Diseases | 1 | 1993 | 75 | 0.010 |
Why?
|
| Membranes, Artificial | 1 | 1973 | 30 | 0.010 |
Why?
|
| Obesity | 1 | 2004 | 2410 | 0.010 |
Why?
|
| Oxyhemoglobins | 1 | 1992 | 25 | 0.010 |
Why?
|
| Counterpulsation | 1 | 1992 | 5 | 0.010 |
Why?
|
| Hematuria | 1 | 1973 | 55 | 0.010 |
Why?
|
| Electronics, Medical | 1 | 1992 | 10 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 1996 | 1667 | 0.010 |
Why?
|
| Body Surface Area | 1 | 1992 | 35 | 0.010 |
Why?
|
| Electrodes | 1 | 1992 | 97 | 0.010 |
Why?
|
| Lipoproteins, HDL | 1 | 1993 | 117 | 0.010 |
Why?
|
| Lipoproteins, LDL | 1 | 1993 | 138 | 0.010 |
Why?
|
| Intensive Care Units | 1 | 1996 | 539 | 0.010 |
Why?
|
| Death | 1 | 1993 | 80 | 0.010 |
Why?
|
| Aortic Valve | 2 | 1991 | 454 | 0.010 |
Why?
|
| Hematoma | 1 | 1972 | 94 | 0.010 |
Why?
|
| Cineradiography | 1 | 1991 | 4 | 0.010 |
Why?
|
| Internal Mammary-Coronary Artery Anastomosis | 1 | 1991 | 15 | 0.010 |
Why?
|
| HLA Antigens | 1 | 1993 | 253 | 0.010 |
Why?
|
| Cyclosporins | 1 | 1991 | 74 | 0.010 |
Why?
|
| Azathioprine | 1 | 1991 | 56 | 0.010 |
Why?
|
| Noise | 1 | 1991 | 21 | 0.010 |
Why?
|
| Heart Injuries | 2 | 1968 | 46 | 0.010 |
Why?
|
| Software | 1 | 1996 | 737 | 0.010 |
Why?
|
| Gene Amplification | 1 | 1992 | 247 | 0.010 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1990 | 40 | 0.010 |
Why?
|
| Methylprednisolone | 1 | 1991 | 104 | 0.010 |
Why?
|
| CD4 Antigens | 1 | 1990 | 58 | 0.010 |
Why?
|
| CD8 Antigens | 1 | 1990 | 45 | 0.010 |
Why?
|
| Constriction, Pathologic | 1 | 1991 | 241 | 0.010 |
Why?
|
| Vital Capacity | 1 | 1990 | 79 | 0.010 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 1990 | 90 | 0.010 |
Why?
|
| Trachea | 2 | 1974 | 212 | 0.010 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 1972 | 239 | 0.010 |
Why?
|
| Length of Stay | 1 | 1996 | 1380 | 0.010 |
Why?
|
| Heart Rate | 3 | 1981 | 601 | 0.010 |
Why?
|
| Forced Expiratory Volume | 1 | 1990 | 174 | 0.010 |
Why?
|
| Angioplasty, Balloon | 1 | 1991 | 162 | 0.010 |
Why?
|
| Gangrene | 1 | 1969 | 27 | 0.010 |
Why?
|
| Drainage | 2 | 1968 | 265 | 0.010 |
Why?
|
| Bronchi | 1 | 1990 | 108 | 0.010 |
Why?
|
| Cytomegalovirus Infections | 1 | 1992 | 228 | 0.010 |
Why?
|
| Blood Vessels | 1 | 1970 | 108 | 0.000 |
Why?
|
| Acute Kidney Injury | 1 | 1977 | 686 | 0.000 |
Why?
|
| Vertebral Artery | 2 | 1980 | 24 | 0.000 |
Why?
|
| Electromagnetic Phenomena | 1 | 1989 | 4 | 0.000 |
Why?
|
| Regression Analysis | 1 | 1991 | 830 | 0.000 |
Why?
|
| Lymphocyte Activation | 1 | 1991 | 724 | 0.000 |
Why?
|
| Infant, Newborn | 2 | 1992 | 8574 | 0.000 |
Why?
|
| Pulmonary Emphysema | 1 | 1970 | 95 | 0.000 |
Why?
|
| Gram-Negative Bacteria | 1 | 1989 | 73 | 0.000 |
Why?
|
| Iliac Artery | 1 | 1989 | 81 | 0.000 |
Why?
|
| Vascular Patency | 1 | 1989 | 196 | 0.000 |
Why?
|
| Pulmonary Alveoli | 1 | 1989 | 142 | 0.000 |
Why?
|
| Neck Injuries | 1 | 1968 | 24 | 0.000 |
Why?
|
| Physical Exertion | 1 | 1988 | 77 | 0.000 |
Why?
|
| Multicenter Studies as Topic | 1 | 1989 | 290 | 0.000 |
Why?
|
| Influenza, Human | 1 | 1974 | 691 | 0.000 |
Why?
|
| Mycoses | 1 | 1989 | 121 | 0.000 |
Why?
|
| Drug Therapy, Combination | 1 | 1991 | 1197 | 0.000 |
Why?
|
| Lovastatin | 1 | 1987 | 23 | 0.000 |
Why?
|
| Diastole | 1 | 1988 | 185 | 0.000 |
Why?
|
| Abdominal Injuries | 1 | 1968 | 117 | 0.000 |
Why?
|
| Abscess | 1 | 1968 | 141 | 0.000 |
Why?
|
| Critical Care | 1 | 1992 | 689 | 0.000 |
Why?
|
| Stress, Mechanical | 1 | 1987 | 178 | 0.000 |
Why?
|
| Bacterial Infections | 1 | 1989 | 325 | 0.000 |
Why?
|
| Accidents, Traffic | 1 | 1966 | 110 | 0.000 |
Why?
|
| Radiography, Thoracic | 1 | 1966 | 152 | 0.000 |
Why?
|
| Adenosine Diphosphate | 2 | 1975 | 55 | 0.000 |
Why?
|
| Laparotomy | 1 | 1966 | 142 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1991 | 1069 | 0.000 |
Why?
|
| Hypercholesterolemia | 1 | 1987 | 234 | 0.000 |
Why?
|
| Blood | 2 | 1976 | 105 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1989 | 1153 | 0.000 |
Why?
|
| Iodipamide | 1 | 1964 | 1 | 0.000 |
Why?
|
| Cholangiography | 1 | 1964 | 15 | 0.000 |
Why?
|
| Diagnostic Errors | 1 | 1988 | 344 | 0.000 |
Why?
|
| Abdomen, Acute | 1 | 1964 | 14 | 0.000 |
Why?
|
| Cholecystitis | 1 | 1964 | 21 | 0.000 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 1976 | 470 | 0.000 |
Why?
|
| Cholecystitis, Acute | 1 | 1964 | 18 | 0.000 |
Why?
|
| Blood Volume Determination | 2 | 1974 | 10 | 0.000 |
Why?
|
| Injections, Intravenous | 1 | 1964 | 254 | 0.000 |
Why?
|
| Abdomen | 1 | 1964 | 134 | 0.000 |
Why?
|
| Thrombocytopenia | 2 | 1975 | 235 | 0.000 |
Why?
|
| Brachiocephalic Trunk | 2 | 1975 | 40 | 0.000 |
Why?
|
| USSR | 1 | 1982 | 5 | 0.000 |
Why?
|
| Hypoxia | 2 | 1974 | 262 | 0.000 |
Why?
|
| Electrocardiography | 2 | 1981 | 1006 | 0.000 |
Why?
|
| Digoxin | 1 | 1981 | 44 | 0.000 |
Why?
|
| Lumbosacral Region | 1 | 1980 | 34 | 0.000 |
Why?
|
| Injections | 1 | 1980 | 159 | 0.000 |
Why?
|
| Neurologic Manifestations | 1 | 1979 | 6 | 0.000 |
Why?
|
| Anesthesia, General | 1 | 1980 | 119 | 0.000 |
Why?
|
| Ligation | 1 | 1979 | 137 | 0.000 |
Why?
|
| Brachial Artery | 1 | 1978 | 42 | 0.000 |
Why?
|
| Arteries | 1 | 1979 | 223 | 0.000 |
Why?
|
| Electric Conductivity | 1 | 1977 | 90 | 0.000 |
Why?
|
| Vascular Diseases | 1 | 1978 | 158 | 0.000 |
Why?
|
| Skin | 1 | 1980 | 551 | 0.000 |
Why?
|
| Blood Proteins | 1 | 1977 | 135 | 0.000 |
Why?
|
| Cold Temperature | 1 | 1975 | 86 | 0.000 |
Why?
|
| Sheep | 1 | 1976 | 237 | 0.000 |
Why?
|
| Embolism, Air | 1 | 1975 | 25 | 0.000 |
Why?
|
| Blood Volume | 1 | 1975 | 83 | 0.000 |
Why?
|
| Pressure | 1 | 1975 | 138 | 0.000 |
Why?
|
| Orthomyxoviridae | 1 | 1974 | 52 | 0.000 |
Why?
|
| Hemoglobinometry | 1 | 1974 | 4 | 0.000 |
Why?
|
| Partial Pressure | 1 | 1974 | 29 | 0.000 |
Why?
|
| Microscopy, Electron | 1 | 1974 | 374 | 0.000 |
Why?
|
| Nylons | 1 | 1974 | 13 | 0.000 |
Why?
|
| Telemetry | 1 | 1973 | 28 | 0.000 |
Why?
|
| Air | 1 | 1973 | 26 | 0.000 |
Why?
|
| Central Venous Pressure | 1 | 1973 | 26 | 0.000 |
Why?
|
| Lactates | 1 | 1973 | 97 | 0.000 |
Why?
|
| Polymers | 1 | 1974 | 121 | 0.000 |
Why?
|
| Potassium | 1 | 1974 | 289 | 0.000 |
Why?
|
| Feedback | 1 | 1974 | 167 | 0.000 |
Why?
|
| Chick Embryo | 1 | 1973 | 131 | 0.000 |
Why?
|
| Sodium | 1 | 1974 | 307 | 0.000 |
Why?
|
| Blood Platelets | 1 | 1975 | 342 | 0.000 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1975 | 1735 | 0.000 |
Why?
|
| Collateral Circulation | 1 | 1970 | 45 | 0.000 |
Why?
|
| Trypsin Inhibitors | 1 | 1970 | 6 | 0.000 |
Why?
|
| Alpha-Globulins | 1 | 1970 | 11 | 0.000 |
Why?
|
| Brachiocephalic Veins | 1 | 1970 | 14 | 0.000 |
Why?
|
| Carotid Artery Injuries | 1 | 1970 | 38 | 0.000 |
Why?
|
| Isoproterenol | 1 | 1969 | 109 | 0.000 |
Why?
|
| Glucagon | 1 | 1969 | 184 | 0.000 |
Why?
|
| Tricuspid Valve | 1 | 1969 | 63 | 0.000 |
Why?
|
| Surgical Wound Infection | 1 | 1970 | 276 | 0.000 |
Why?
|
| Lymphocytes | 1 | 1970 | 440 | 0.000 |
Why?
|
| Pneumothorax | 1 | 1968 | 82 | 0.000 |
Why?
|
| Tracheotomy | 1 | 1967 | 36 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 1979 | 2082 | 0.000 |
Why?
|
| Wounds and Injuries | 1 | 1970 | 399 | 0.000 |
Why?
|
| Vascular Surgical Procedures | 1 | 1970 | 559 | 0.000 |
Why?
|
| Heart Defects, Congenital | 1 | 1969 | 1874 | 0.000 |
Why?
|